The Morrissey data is not pivotal to the imidacloprid decision in indicating risk at this time. The more pivotal pieces of information are from Ontario and Quebec. The Morrissey data comes largely from areas where the other two neonics are used more extensively—that would be thiamethoxam and clothianidin—and that information will figure in our special reviews of those two chemicals. With respect to imidacloprid, there is some use in the area where Dr. Morrissey did her work, but it is not to the extent of the other two.
On March 7th, 2017. See this statement in context.